397 related articles for article (PubMed ID: 9771768)
1. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
Ford B; Louis ED; Greene P; Fahn S
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
[TBL] [Abstract][Full Text] [Related]
2. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.
Münchau A; Palmer JD; Dressler D; O'Sullivan JD; Tsang KL; Jahanshahi M; Quinn NP; Lees AJ; Bhatia KP
Brain; 2001 Apr; 124(Pt 4):769-83. PubMed ID: 11287376
[TBL] [Abstract][Full Text] [Related]
4. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
Kaufman DM
J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
[TBL] [Abstract][Full Text] [Related]
5. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
Domzał TM
Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin therapy for cervical dystonia.
Walker FO
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
[TBL] [Abstract][Full Text] [Related]
7. Selective peripheral denervation for spasmodic torticollis: 13-year experience with 155 patients.
Braun V; Richter HP
J Neurosurg; 2002 Sep; 97(2 Suppl):207-12. PubMed ID: 12296680
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
Figgitt DP; Noble S
Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.
Berman B; Seeberger L; Kumar R
Mov Disord; 2005 Feb; 20(2):233-7. PubMed ID: 15455449
[TBL] [Abstract][Full Text] [Related]
11. Selective peripheral denervation for the treatment of spasmodic torticollis.
Braun V; Richter HP
Neurosurgery; 1994 Jul; 35(1):58-62; discussion 62-3. PubMed ID: 7936153
[TBL] [Abstract][Full Text] [Related]
12. Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.
Nijmeijer SW; Koelman JH; Kamphuis DJ; Tijssen MA
Parkinsonism Relat Disord; 2012 Jul; 18(6):731-6. PubMed ID: 22575237
[TBL] [Abstract][Full Text] [Related]
13. Selective peripheral denervation for spasmodic torticollis: is the outcome predictable?
Braun V; Richter HP; Schröder JM
J Neurol; 1995 Aug; 242(8):504-7. PubMed ID: 8530977
[TBL] [Abstract][Full Text] [Related]
14. Treatment of idiopathic spasmodic torticollis with botulinum-A toxin: a pilot study of 19 patients.
Lorentz IT; Subramaniam SS; Yiannikas C
Med J Aust; 1990 May; 152(10):528-30. PubMed ID: 2338926
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
[TBL] [Abstract][Full Text] [Related]
16. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
Poungvarin N; Viriyavejakul A
J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
[TBL] [Abstract][Full Text] [Related]
17. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.
van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA
BMC Neurol; 2013 Jul; 13():85. PubMed ID: 23855591
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.
Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):601-7. PubMed ID: 7500097
[TBL] [Abstract][Full Text] [Related]
19. Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.
Poewe W; Schelosky L; Kleedorfer B; Heinen F; Wagner M; Deuschl G
J Neurol; 1992 Jan; 239(1):21-5. PubMed ID: 1541964
[TBL] [Abstract][Full Text] [Related]
20. Resistance to botulinum toxin injections for spasmodic dysphonia.
Smith ME; Ford CN
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
